Home > Publications database > c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. > print

001     307267
005     20251218120131.0
024 7 _ |a 10.1186/s12943-025-02486-5
|2 doi
024 7 _ |a pmid:41398670
|2 pmid
037 _ _ |a DKFZ-2025-02960
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Bakırdöğen, D.
|b 0
245 _ _ |a c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT.
260 _ _ |a London
|c 2025
|b Biomed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1765976847_2398476
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Anchorage independence
|2 Other
650 _ 7 |a CD61
|2 Other
650 _ 7 |a FN1
|2 Other
650 _ 7 |a Fibronectin
|2 Other
650 _ 7 |a Integrin β3
|2 Other
650 _ 7 |a Metastasis
|2 Other
650 _ 7 |a NF-κB
|2 Other
650 _ 7 |a PDAC
|2 Other
650 _ 7 |a c-Rel
|2 Other
700 1 _ |a Görgülü, K.
|b 1
700 1 _ |a Xin, J.
|b 2
700 1 _ |a Richter, L.
|b 3
700 1 _ |a Alcalá, S.
|b 4
700 1 _ |a Ruiz-Cañas, L.
|b 5
700 1 _ |a Dai, C.
|b 6
700 1 _ |a Frank, K. J.
|b 7
700 1 _ |a Wu, N.
|b 8
700 1 _ |a Diakopoulos, K. N.
|b 9
700 1 _ |a Ozturk, H.
|b 10
700 1 _ |a Demircioğlu, D.
|b 11
700 1 _ |a Peschke, K.
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Ranjan, R.
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Fusco, F.
|b 14
700 1 _ |a Martinez-Useros, J.
|b 15
700 1 _ |a Fernandez-Aceñero, M. J.
|b 16
700 1 _ |a Chhabra, N. F.
|b 17
700 1 _ |a López-Gil, J. C.
|b 18
700 1 _ |a Ai, J.
|b 19
700 1 _ |a Ruess, D. A.
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Kaya-Aksoy, E.
|b 21
700 1 _ |a Schmidt, F.
|b 22
700 1 _ |a Kohlmann, L.
|b 23
700 1 _ |a Berninger, A.
|b 24
700 1 _ |a Yangin, H.
|b 25
700 1 _ |a Schicktanz, F.
|b 26
700 1 _ |a Steiger, K.
|b 27
700 1 _ |a Demir, I. E.
|b 28
700 1 _ |a Schmid, R. M.
|b 29
700 1 _ |a Reichert, M.
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Adli, M.
|b 31
700 1 _ |a Lesina, M.
|b 32
700 1 _ |a Sainz, B.
|b 33
700 1 _ |a Algül, H.
|b 34
773 _ _ |a 10.1186/s12943-025-02486-5
|0 PERI:(DE-600)2091373-4
|p nn
|t Molecular cancer
|v nn
|y 2025
|x 1476-4598
909 C O |o oai:inrepo02.dkfz.de:307267
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL CANCER : 2022
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:06:41Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:06:41Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T09:06:41Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-10
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-10
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b MOL CANCER : 2022
|d 2024-12-10
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-10
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-10
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
920 1 _ |0 I:(DE-He78)FR01-20160331
|k FR01
|l DKTK Koordinierungsstelle Freiburg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a I:(DE-He78)FR01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21